NBRV logo

Nabriva Therapeutics (NBRV) Total Liabilities

Annual Total Liabilities

$28.47 M
+$913.00 K+3.31%

December 31, 2022


Summary


Performance

NBRV Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherNBRVbalance sheetmetrics:

Quarterly Total Liabilities

$28.70 M
+$223.00 K+0.78%

March 31, 2023


Summary


Performance

NBRV Quarterly Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherNBRVbalance sheetmetrics:

Total Liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

NBRV Total Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+3.3%+35.6%
3 y3 years-46.1%+36.1%
5 y5 years+107.9%+138.7%

NBRV Total Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-3.2%at high-29.3%
5 y5-year-46.1%-11.1%-45.7%-29.3%
alltimeall time-46.1%-68.4%-45.7%-68.6%

Nabriva Therapeutics Total Liabilities History

DateAnnualQuarterly
Mar 2023
-
$28.70 M(+0.8%)
Dec 2022
$28.47 M(+3.3%)
$28.47 M(+25.9%)
Sep 2022
-
$22.62 M(+11.5%)
Jun 2022
-
$20.29 M(-4.1%)
Mar 2022
-
$21.16 M(-23.2%)
Dec 2021
$27.56 M(+8.9%)
$27.56 M(+6.7%)
Sep 2021
-
$25.83 M(-1.4%)
Jun 2021
-
$26.21 M(+7.3%)
Mar 2021
-
$24.42 M(-3.5%)
Dec 2020
$25.30 M(-52.1%)
$25.30 M(+23.2%)
Sep 2020
-
$20.54 M(-0.2%)
Jun 2020
-
$20.59 M(-2.4%)
Mar 2020
-
$21.09 M(-60.1%)
Dec 2019
$52.84 M(+26.4%)
$52.84 M(+3.8%)
Sep 2019
-
$50.91 M(+26.5%)
Jun 2019
-
$40.24 M(-8.3%)
Mar 2019
-
$43.88 M(+5.0%)
DateAnnualQuarterly
Dec 2018
$41.79 M(+205.1%)
$41.79 M(+160.9%)
Sep 2018
-
$16.02 M(+32.2%)
Jun 2018
-
$12.12 M(+0.8%)
Mar 2018
-
$12.02 M(-12.2%)
Dec 2017
$13.70 M(-14.3%)
$13.70 M(-18.3%)
Sep 2017
-
$16.76 M(-2.1%)
Jun 2017
-
$17.12 M(+5.5%)
Mar 2017
-
$16.23 M(+1.5%)
Dec 2016
$15.98 M(+77.5%)
$15.98 M(+12.1%)
Sep 2016
-
$14.26 M(+17.9%)
Jun 2016
-
$12.10 M(-14.2%)
Mar 2016
-
$14.10 M(+56.6%)
Dec 2015
$9.01 M(-78.3%)
$9.01 M(-31.3%)
Sep 2015
-
$13.11 M(-18.0%)
Jun 2015
-
$15.99 M(-67.3%)
Mar 2015
-
$48.86 M(+17.8%)
Dec 2014
$41.49 M(+35.6%)
$41.49 M
Dec 2013
$30.59 M
-

FAQ

  • What is Nabriva Therapeutics annual total liabilities?
  • What is the all time high annual total liabilities for Nabriva Therapeutics?
  • What is Nabriva Therapeutics annual total liabilities year-on-year change?
  • What is Nabriva Therapeutics quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Nabriva Therapeutics?
  • What is Nabriva Therapeutics quarterly total liabilities year-on-year change?

What is Nabriva Therapeutics annual total liabilities?

The current annual total liabilities of NBRV is $28.47 M

What is the all time high annual total liabilities for Nabriva Therapeutics?

Nabriva Therapeutics all-time high annual total liabilities is $52.84 M

What is Nabriva Therapeutics annual total liabilities year-on-year change?

Over the past year, NBRV annual total liabilities has changed by +$913.00 K (+3.31%)

What is Nabriva Therapeutics quarterly total liabilities?

The current quarterly total liabilities of NBRV is $28.70 M

What is the all time high quarterly total liabilities for Nabriva Therapeutics?

Nabriva Therapeutics all-time high quarterly total liabilities is $52.84 M

What is Nabriva Therapeutics quarterly total liabilities year-on-year change?

Over the past year, NBRV quarterly total liabilities has changed by +$7.54 M (+35.64%)